1. Labeler Index
  2. Astrazeneca Pharmaceuticals Lp
  3. 0310-1730
  4. NDC Package Code: 0310-1730-30 Fasenra

NDC Package 0310-1730-30 Fasenra

Benralizumab Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0310-1730-30
Package Description:
1 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS
Product Code:
0310-1730
Proprietary Name:
Fasenra
Non-Proprietary Name:
Benralizumab
Substance Name:
Benralizumab
Usage Information:
Benralizumab is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
00310173030
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1989104 - benralizumab 30 MG in 1 ML Prefilled Syringe
  • RxCUI: 1989104 - 1 ML benralizumab 30 MG/ML Prefilled Syringe
  • RxCUI: 1989104 - benralizumab 30 MG per 1 ML Prefilled Syringe
  • RxCUI: 1989109 - Fasenra 30 MG in 1 ML Prefilled Syringe
  • RxCUI: 1989109 - 1 ML benralizumab 30 MG/ML Prefilled Syringe [Fasenra]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Astrazeneca Pharmaceuticals Lp
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • BENRALIZUMAB 30 mg/mL
    • Pharmacologic Class(es):
  • Interleukin 5 Receptor alpha-directed Antibody Interactions - [MoA] (Mechanism of Action)
  • Interleukin-5 Receptor alpha-directed Cytolytic Antibody - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA761070
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    11-14-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0310-1730-30 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00310173030J0517Inj., benralizumab, 1 mg1 MG113030

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0310-1730-851 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0310-1730-30?

    The NDC Packaged Code 0310-1730-30 is assigned to a package of 1 syringe, glass in 1 carton / 1 ml in 1 syringe, glass of Fasenra, a human prescription drug labeled by Astrazeneca Pharmaceuticals Lp. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 0310-1730 included in the NDC Directory?

    Yes, Fasenra with product code 0310-1730 is active and included in the NDC Directory. The product was first marketed by Astrazeneca Pharmaceuticals Lp on November 14, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0310-1730-30?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0310-1730-30?

    The 11-digit format is 00310173030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20310-1730-305-4-200310-1730-30